Healthy Clinical Trial
Official title:
The Effects of Sevoflurane, Propofol, and Carbon Dioxide 'Reversal' on Upper Airway Collapsibility in Healthy, Adult Subjects
The investigators hypothesize that propofol, when compared to sevoflurane, causes the upper airway to collapse more easily and causes less activity in the tongue muscle. Additionally, the investigators hypothesize that, under increased carbon dioxide concentrations of the air inhaled, the upper airway will be less likely to collapse under anesthesia and there will be increased activity in the tongue muscle under both propofol and sevoflurane, when compared to breathing normal concentrations of carbon dioxide, as in room air.
Upper airway patency depends on an appropriate balance between the dilating force of
pharyngeal muscles and the collapsing force of negative intraluminal pressure, which is
generated by respiratory "pump" muscles. The genioglossus (GG) protects pharyngeal patency
in humans. This muscle receives various types of neural drive, distributed differentially
across the hypoglossal motoneuron pool, including phasic (inspiratory) and tonic
(non-respiratory) drives. In addition, reflex GG activation in response to negative
pharyngeal pressure stabilizes upper airway patency both in humans and in rats. General
anesthetic agents, including propofol and sevoflurane, predispose the upper airway to
collapse, at least in part by decreasing upper airway muscle activity.
Theoretically anesthetics could affect upper airway dilator activity by several mechanisms,
including an anesthetic-induced, dose-dependent decrease in hypercapnic and hypoxic
ventilatory drive, hypoglossal motoneuron depression, decreased skeletal muscle
contractility, an increase in phasic GG activity as a result of decreased arterial blood
pressure, and an increase in phasic hypoglossal nerve discharge.
Previous studies have shown that certain anesthetics, including pentobarbital and
isoflurane, can increase genioglossus phasic activity in rats and in humans. The effects of
propofol on airway collapsibility have been studied in humans however, to our knowledge,
they have not been measured under conditions of hypercapnia. Studies of airway
collapsibility under sevoflurane anesthesia have been performed in children, but no data
exists for airway collapsibility in sevoflurane-anesthetized adults. Similarly no data
exists on the effects of sevoflurane on GG activity
In a previous trial of pentobarbital-anesthetized volunteers, the investigators observed
that mild hypercapnia (5 - 10 mmHg above baseline) produced a significant increase in flow
rate and GG phasic activity, as well as a smaller increase in GG tonic activity. If our
proposed study shows a beneficial effect, then the investigators plan a follow-up study
addressing the possibility that hypercapnia may be used therapeutically for airway
protection. A similar concept has already been considered for critically ill ICU patients.
Comparative drug studies on airway effects of anesthetics in humans are important for
defining an optimal anesthetic regimen for patients at risk of airway collapse, such as
patients with obstructive sleep apnea. Our studies are also particularly relevant for
patients undergoing procedural sedation, which is typically being conducted under
spontaneous ventilation with the upper airway being unprotected. In addition, our results
may increase our understanding of postoperative airway obstruction, a common complication in
the post-anesthesia recovery room.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |